Shingles

Infectious Disease·MeSH: Chickenpox

11 drugs in development·4 companies·3 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
CpG 1018	DYNAVAX TECHNOLOGIES CORP (DVAX)

Phase 2(4)

Drug	Company
candidate 1	PFIZER INC (PFE)
candidate 2	PFIZER INC (PFE)
candidate 3	PFIZER INC (PFE)
Z-1018	DYNAVAX TECHNOLOGIES CORP (DVAX)

Phase 1(1)

Drug	Company
Tdap-1018	DYNAVAX TECHNOLOGIES CORP (DVAX)

Preclinical(3)

Drug	Company
anti-infective antibody	XBiotech Inc. (XBIT)
nv-hhv-1	NANOVIRICIDES, INC. (NNVC)
varicella zoster therapeutic	XBiotech Inc. (XBIT)

Phase 1/Phase 2(2)

Drug	Company
shingrix	PFIZER INC (PFE)
Shingrix	DYNAVAX TECHNOLOGIES CORP (DVAX)

BioSniper tracks 11 drugs in development for Shingles across 4 companies.

There are 3 clinical trials targeting Shingles tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.